Home > Income Statement > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Revenue

    Back to Income Statement
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹40 Cr₹31 Cr₹6,052,481 Cr₹52 Cr₹14 Cr

What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?

The latest Revenue ratio of OXYGENTA PHARMACEUTICAL is ₹40 Cr based on Mar2025 Standalone results.
Year Revenue
Mar2025₹40 Cr
Mar2024₹31 Cr
Mar2023₹6,052,481 Cr
Mar2022₹52 Cr
Mar2021₹14 Cr

How is Revenue of OXYGENTA PHARMACEUTICAL Trending?

Years Revenue % Change
Mar2025 ₹40 Cr
27.93
Mar2024 ₹31 Cr
-100.00
Mar2023 ₹6,052,481 Cr
11,633,245.46
Mar2022 ₹52 Cr
279.32
Mar2021 ₹14 Cr -

Compare Revenue of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹185.4 Cr -0.9% -14.4% -29.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,855.0 Cr 2.4% 7.1% 14.6% Stock Analytics
DIVIS LABORATORIES ₹168,550.0 Cr -0.2% 3.8% 15.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,906.0 Cr 1.8% 10.9% 48.4% Stock Analytics
DR REDDYS LABORATORIES ₹110,632.0 Cr 1% 4% 16.6% Stock Analytics
CIPLA ₹107,427.0 Cr 0.3% -0.9% -6% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-0.9%

-14.4%

-29.1%

SENSEX

-2.9%

-8%

5.3%


You may also like the below Video Courses